Glenbrook Capital Management, a significant 10% owner and director of SenesTech, Inc. (NASDAQ:SNES), has executed a notable purchase of the biotechnology company's common stock. On July 20, 2026, the investment manager acquired 35,000 shares at a price of $1.4734 per share, resulting in a total transaction value of $51,569. This acquisition is particularly notable given the current market context for SNES, which is trading near its 52-week low of $1.34. Over the past year, the stock has experienced a significant decline of 76%.
Following this recent transaction, Glenbrook Capital Management's indirect holdings in SenesTech common stock have increased to 1,057,824 shares. These securities are held directly by an account for which Glenbrook Capital Management serves as the investment manager. While the reporting person disclaims beneficial ownership of these securities, they retain this disclaimer except to the extent of their pecuniary interest.
In terms of recent financial performance, SenesTech Inc. reported a 2% increase in revenue for the first quarter of 2026. The company's revenue reached $493,000, an increase from the $485,000 recorded in the same period last year. Additionally, SenesTech achieved a record gross margin of 68.6%, a notable improvement from the 64.5% reported in Q1 2025.
Strategically, SenesTech has announced a distribution agreement with Animal and Garden House to introduce its Evolve Rodent Birth Control products to the Bermuda market. This expansion comes as traditional rodenticides face regulatory challenges in Bermuda due to environmental concerns. Furthermore, the company's Board of Directors has revised its proposal to increase shares under the company's 2018 Equity Incentive Plan. The requested amount has been reduced from 1.7 million shares to 1.2 million shares, with the amendment to be presented to stockholders for approval at the annual meeting in June 2026. In leadership news, SenesTech appointed Jack Karabees as Executive Vice President of Sales. Karabees brings over 30 years of experience in B2B sales to lead revenue growth and market expansion efforts.
SenesTech Inc. (SNES) is currently trading at $1.38, reflecting a decrease of $0.0250 or 1.78% from the previous close. Pre-market trading shows a slight increase of $0.0100 or 0.72% at 05:57:33. The stock's 1D, 1W, 1M, 6M, 1Y, 5Y, and Max performance metrics are available for analysis.